This report shows public data only. Is this your organisation? If so, login here to view your full report.

Groupama Asset Management

PRI reporting framework 2020

Export Public Responses
Pdf-img

You are in Direct - Listed Equity Active Ownership » Outputs and outcomes

Outputs and outcomes

LEA 09. Number of companies engaged with, intensity of engagement and effort (Private)


LEA 10. Engagement methods

10.1. Indicate which of the following your engagement involved.

(specify)

          ESG research and analysis
        

10.2. Additional information. [Optional]

Our ESG meetings and letters sent influence the ESG analysis of a company. Dialog impacts investment decisions as it modifies the rating and the fundamental analysis of an issuer. For company meetings organised with analysts and portfolio managers, the way the company responds to our ESG questions may have a direct impact on the investment decisions.

All meetings and other initiatives are registered in an internal tool, where each analyst specifies which questions were raised and what were the main subjects of dialog. This tool is accessible to fund managers, enabling a formal and structured process to be implemented. It enables the selection, the validation and the follow-up of the actions of collaborative engagement.

A formal and structured process is being implemented. It will allow the selection, the validation and the follow-up of the actions of collaborative engagement. All collaborative actions are tracked and we record calls and interactions dates as well as results and progress.

A report of our commitment is issued each year and available in our website.


LEA 11. Examples of ESG engagements

11.1. Provide examples of the engagements that your organisation or your service provider carried out during the reporting year.

ESG Topic
Climate Change|General ESG|Anti-bribery and corruption|Cyber security
Conducted by
Objectives


We focus on the companies that face recurrent and material controversies. We inform them that they are on our ESG Main Risks List  and we discuss about the controversial topics.
 

Scope and Process

The companies that are deemed facing recurrent and severe ESG controversies, and that are added on Groupama AM ESG controversies list.

Outcomes
ESG Topic
Executive Remuneration|General ESG|Other governance
Conducted by
Objectives

Improve the transparency of the components of individual executive remuneration and encourage the inclusion of ESG criteria in remuneration policies. Improve the governance structure.

Scope and Process

All companies we met before their AGM's.

The companies are encouraged to the publication of a summary table indicating all the items of remuneration due and paid. We present them our voting policy and discuss about the best practices and standards of governance policy.

Outcomes
ESG Topic
General ESG|Health and Safety
Conducted by
Objectives

Ensuring the continued eligibility of companies invested in thematic fund.

Scope and Process

Companies invested in our thematic fund and suspected of facing a controversy related to health and safety of products, which is one of the themes of the fund. 

We engaged a writen dialog with two companies , which represented a significative part of the total asset of the fund. Both companies answered and brougt us the explanations.

Outcomes
ESG Topic
Company leadership issues|General ESG
Conducted by
Objectives

 

Improving the transparency of human resources strategy and the HR key performance indicators.

 

Scope and Process

One company was identified by our internal analysis as presenting risks in terms of human resources management, which is a strategic issue. We held a conference call with the company and then engaged in a written dialogue on the key issues. The company is very receptive and the dialogue is still ongoing.

Outcomes
ESG Topic
Human rights|General ESG
Conducted by
Objectives

Improve the transparency of  human rights due diligence plan 

Scope and Process

We engaged a regular dialog with one company, for which is a key issue and in which we are a significant shareholder

Outcomes

11.2. Additional information. [Optional]


Top